Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Basel Medical GroupBMGL -10.42%17 Days Payable is 159.06 as of Dec. 2025, which is 17% below its 10-year median of 191.53. GuruFocus rates BMGL with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Basel Medical Group ranks better than 80.59% on this metric.
The historical rank and industry rank for Basel Medical Group's Days Payable or its related term are showing as below:
BMGL'
s Days Payable Range Over the Past 10 Years
Min: 160.18 Med: 191.53 Max: 203.22
Current: 160.18
During the past 4 years, Basel Medical Group's highest Days Payable was 203.22. The lowest was 160.18. And the median was 191.53.
BMGL's Days Payable is ranked better than 80.59% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 57.32
vs BMGL: 160.18
Basel Medical Group's Days Payable
declined
from Dec. 2024 (174.40) to Dec. 2025 (159.06).
It may suggest that Basel Medical Groupaccelerated paying its suppliers.
Basel Medical Group Days Payable Related Terms
Basel Medical Group Days Payable Historical Data
* Premium members only.
The historical data trend for Basel Medical Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Basel Medical Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Basel Medical Group Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Basel Medical Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Basel Medical Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Basel Medical Group's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Basel Medical Group (BMGL) has a Days Payable of 159.06 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Basel Medical Group and its competitors. This is 17% below median its historical median of 191.53. Over the past decade, Basel Medical Group's Days Payable has ranged from 160.18 to 203.22. According to the industry distribution chart, Basel Medical Group ranks #118 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 19.4%.
Is Basel Medical Group's Days Payable too high?
Basel Medical Group's current Days Payable of 159.06 is 17% below median its 10-year median of 191.53. Over the past 10 years, this metric has ranged from a low of 160.18 to a high of 203.22. The Healthcare Providers & Services industry median Days Payable is 57.32. Basel Medical Group's value of 159.06 is 177.5% above this industry median. Based on the distribution chart, Basel Medical Group ranks #118 out of 608 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Basel Medical Group has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Basel Medical Group's Days Payable compare to AMS and HLYK?
According to the Healthcare Providers & Services industry distribution chart, Basel Medical Group ranks #118 out of 608 companies for Days Payable. This places Basel Medical Group in the top 19% of its industry — outperforming the majority of peers. The industry median Days Payable is 57.32. Basel Medical Group's value of 159.06 is 177.5% above this benchmark. Historically, Basel Medical Group's own Days Payable has ranged from 160.18 to 203.22 over the past decade. While the company's 10-year median is 191.53 vs. the industry median of 57.32, Basel Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.32, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Basel Medical Group's current Days Payable of 159.06 is 177.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Basel Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Basel Medical Group's current Days Payable is 159.06, which is 17% below median its own 10-year median of 191.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Basel Medical Group stock overvalued right now?
Basel Medical Group (BMGL) has a current Days Payable of 159.06. The current Days Payable is 159.06, which is 17% below median its 10-year median of 191.53 and 177.5% above the Healthcare Providers & Services industry median of 57.32. Basel Medical Group's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Basel Medical Group (BMGL), the current Days Payable is 159.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.
17GF Score
Get the complete analysis for BMGL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BMGL has been successfully added to your 
